Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2631500 | 0.82 | CA1 (0.37) | SMN1; SMN2NPC1CYP1A2CYP2C9CYP2C19 | |
| SCHEMBL23741102 | 0.81 | SMN1; SMN2 (0.34) | SMN1; SMN2NPC1CYP1A2CYP2C9CYP2C19 | |
| SCHEMBL23916136 | 0.81 | SMN1; SMN2 (0.34) | SMN1; SMN2NPC1CYP1A2CYP2C9CYP2C19 | |
| SCHEMBL23048580 | 0.76 | SMN1; SMN2 (0.38) | SMN1; SMN2NPC1CYP1A2CYP2C9CYP2C19 | |
| SCHEMBL2622445 | 0.76 | ALDH1A1 (0.46) | SMN1; SMN2NPC1CYP1A2CYP2C9CYP2C19 | |
| SCHEMBL23453886 | 0.75 | LMNA (0.34) | SMN1; SMN2NPC1CYP1A2CYP2C9CYP2C19 | |
| SCHEMBL1106504 | 0.72 | SMN1; SMN2 (0.41) | SMN1; SMN2NPC1CYP1A2CYP2C9CYP2C19 | |
| SCHEMBL23457041 | 0.66 | SLC6A2 (0.42) | SMN1; SMN2NPC1RAB9AALDH1A1TP53 | |
| SCHEMBL22957136 | 0.65 | CA1 (0.35) | SMN1; SMN2NPC1CYP1A2RAB9A | |
| SCHEMBL22606902 | 0.65 | CA1 (0.35) | SMN1; SMN2NPC1CYP1A2RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3892276-A1 | ISOQUINOLIN-3-YL CARBOXAMIDES AS WNT INHIBITORS | BioSplice Therapeutics, Inc. (US) | 2021-10-13 | — | — | EP | disclosed |